Table 2.
The activities of AST, ALT, ALP, LDH, levels of MDA, total protein, albumin, urea, and creatinine after lead exposure and Omega-3 treatment in serum of female rats.
| Parameters | Experimental groups | |||
|---|---|---|---|---|
| (Group 1) −ve control |
(Group 2) Omega-3 (125 mg/kg b.w.) + lead acetate |
(Group 3) Omega-3 (260 mg/kg b.w.) + lead acetate |
(Group 4) +ve control |
|
| AST (U/L) | 56.69 ± 0.565a | 58.63 ± 1.279a | 51.35 ± 0.373a | 104.27 ± 0.677b |
| ALT (U/L) | 36.32 ± 0.276a | 40.53 ± 0.260a | 38.69 ± 0.416a | 90.07 ± 0.612b |
| ALP (U/L) | 42.43 ± 0.358a | 48.74 ± 0.475a | 41.44 ± 0.279a | 87.77 ± 0.534b |
| LDH (U/L) | 149.29 ± 0.703a | 159.07 ± 0.845a | 148.81 ± 0.845a | 219.88 ± 1.082b |
| Total protein (gm/dL) | 7.10 ± 0.115a | 6.11 ± 0.244a | 7.61 ± 0.217a | 4.88 ± 0.103b |
| Albumin (g/dL) | 3.96 ± 0.095a | 3.75 ± 0.071a | 4.05 ± 0.102a | 2.66 ± 0.083b |
| Urea (mg/dL) | 31.09 ± 0.225a | 40.04 ± 0.715a | 31.59 ± 0.450a | 63.56 ± 0.962b |
| Creatinine (mg/dL) | 0.38 ± 0.004a | 0.47 ± 0.011a | 0.38 ± 0.004a | 0.96 ± 0.026b |
| MDA (nmol/mL) | 17.08 ± 0.296a | 18.81 ± 0.538a | 17.47 ± 0.349a | 51.99 ± 0.620b |
Values are expressed as means ± SE; n = 7 for each treatment group. a, b indicate the significant results statistically; P < 0.05.